Li Dean Y - Insider Non-Derivative Transactions at RECURSION PHARMACEUTICALS, INC. (RXRX) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Oct 1, 2025, Li Dean Y's relationship to RECURSION PHARMACEUTICALS, INC. (RXRX) is Director, and currently has 1,238,528 shares of Class A Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other RXRX insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Li Dean Y - Insider Non-Derivative Transactions of RXRX Class A Common Stock

Li Dean Y - Insider Non-Derivative Transactions at RXRX

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Oct 2, 2025	Acquisition -- (Class A Common Stock)	1961	0	1238528
Jul 2, 2025	Acquisition -- (Class A Common Stock)	1949	0	1236567
Jun 19, 2025	Acquisition -- (Class A Common Stock)	22016	0	1234618
Apr 2, 2025	Acquisition -- (Class A Common Stock)	2268	0	79618
Jan 3, 2025	Acquisition -- (Class A Common Stock)	1647	0	77350
Oct 2, 2024	Acquisition -- (Class A Common Stock)	1925	0	75703
Jul 2, 2024	Acquisition -- (Class A Common Stock)	1592	0	73778
Jun 4, 2024	Acquisition -- (Class A Common Stock)	13097	0	72186
Apr 2, 2024	Acquisition -- (Class A Common Stock)	1267	0	59089
Jan 10, 2024	Sell -- (Class A Common Stock)	962	14.03	421000
Jan 10, 2024	Sell -- (Class A Common Stock)	28038	13.65	421962
Jan 3, 2024	Acquisition -- (Class A Common Stock)	1203	0	1327618
Oct 3, 2023	Acquisition -- (Class A Common Stock)	1659	0	1326415
Jul 4, 2023	Acquisition -- (Class A Common Stock)	1609	0	637461
Jun 17, 2023	Acquisition -- (Class A Common Stock)	12612	0	636021
Apr 22, 2023	G -- (Class A Common Stock)	627705	0	0
Apr 4, 2023	Acquisition -- (Class A Common Stock)	1724	0	623409
Jan 4, 2023	Acquisition -- (Class A Common Stock)	1573	0	621685